Company / Net Debt per Share
Amneal Pharmaceuticals, Inc. Net Debt per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
$13.00
FY2025
5-year range
$13.00 / $17.93
FY2021-FY2025
Trend
-13.8%
vs FY2024
Sector context
#15 of 82
Health Care
What the data says
Amneal Pharmaceuticals, Inc.'s net debt per share of $13.00 is higher than 82% of companies in the Health Care sector (FY2025). Net Debt per Share has declined for 5 consecutive years, from $20.65 in FY2020 to $13.00 in FY2025.
Based on SEC 10-K filings.
13.00 in FY2025 with a 5-year CAGR of -8.8%. Top quartile in the Health Care sector.
Improved from $15.77 to $13.00 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -9.3%
- 5-Year CAGR
- -8.8%
- 10-Year CAGR
- -
Sector benchmark
-5.1% below sector average
Key checks
Key Insights
- Amneal Pharmaceuticals, Inc.'s net debt per share has declined for 5 consecutive years.
- In FY2025, net debt per share decreased 13.8% year-over-year.
- Ranks #15 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $13.00 | -13.8% |
| FY2024 | $15.07 | -4.4% |
| FY2023 | $15.77 | -9.5% |
| FY2022 | $17.43 | -2.8% |
| FY2021 | $17.93 | -13.2% |
| FY2020 | $20.65 | +8.7% |
| FY2019 | $18.99 | -6.2% |
| FY2018 | $20.26 | -100.0% |
| FY2017 | $1370279.00 | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026